Unique ID issued by UMIN | UMIN000040138 |
---|---|
Receipt number | R000045754 |
Scientific Title | Neural basis of therapeutic intervention in neurodevelopmental disorders |
Date of disclosure of the study information | 2020/04/14 |
Last modified on | 2021/12/10 09:48:59 |
Neural basis of therapeutic intervention in neurodevelopmental disorders
Neural basis of therapeutic intervention in neurodevelopmental disorders
Neural basis of therapeutic intervention in neurodevelopmental disorders
Neural basis of therapeutic intervention in neurodevelopmental disorders
Japan |
Attention-Deficit/Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD)
Psychiatry | Adult |
Others
NO
This study is to investigate neural basis of therapeutic interventions such as medication and group therapy for neurodevelopmental disorders including ASD and ADHD. For this purpose, MRI and clinical / cognitive data are longitudinally evaluated before and after a treatment in clinical practice. MRI data include fMRI, resting-state fMRI, structural MRI and Diffusion Tensor Imaging (DTI).
Others
Brain Information
Exploratory
Pragmatic
Not applicable
MRI data (fMRI, resting-state fMRI, structural MRI, and DTI)
Clinical and Cognitive data
Observational
15 | years-old | <= |
Not applicable |
Male and Female
1. ASD and ADHD patients diagnosed by specialists based on DSM-5. Typically developed healthy subjects who agree to participate in this study.
2. Subjects who did not have any serious neuropsychiatric disorders, except for neurodevelopmental disorders, and severe physical illness.
3. Subjects who can understand this study and give written informed consent. A subject under the age of 20 needs informed consent from a legal representative.
4. Age more than 15 years old.
1. Subjects who are regarded inappropriate as a participant by attending psychiatrists.
2. Subjects who fall into the followings; cardiac pacemaker, cerebral artery clip, Implanted medical devices (ICD, cochlear implant, nerve stimulator, other), implanted infusion pump, embedded metal in the body, pregnancy or possibly pregnant, tattoos, permanent makeup and so on. These potential risks for MRI scan are screened by Medical Questionnaire for MRI Scan.
400
1st name | Kato |
Middle name | |
Last name | Nobumasa |
Showa University
Medical Institute of Developmental Disabilities Research
157-8577
6-11-11, Kita-karasuyama, Setagaya, Tokyo 157-8577, JAPAN
0353159357
katon@med.showa-u.ac.jp
1st name | Nakamura |
Middle name | |
Last name | Motoaki |
Showa University
Medical Institute of Developmental Disabilities Research
157-8577
6-11-11, Kita-karasuyama, Setagaya, Tokyo 157-8577, JAPAN
0353159357
motoaki@med.showa-u.ac.jp
Japan Agency for Medical Research and Development (AMED)
Japan Agency for Medical Research and Development (AMED)
Japanese Governmental office
Institutional Review Board of Showa University, Karasuyama Hospital
6-11-11, Kita-karasuyama, Setagaya, Tokyo 157-8577, JAPAN
03-3300-5247
scri@ofc.showa-u.ac.jp
NO
2020 | Year | 04 | Month | 14 | Day |
Unpublished
Preinitiation
2020 | Year | 04 | Month | 10 | Day |
2020 | Year | 04 | Month | 03 | Day |
2020 | Year | 05 | Month | 07 | Day |
2024 | Year | 03 | Month | 31 | Day |
In this observational study, MRI and clinical / cognitive data are longitudinally collected before and after treatment selected in clinical practice of neurodevelopmental disorders such as ASD and ADHD. MRI data include fMRI, resting-state fMRI, structural MRI and DTI. Clinical / cognitive evaluations include ADOS-2, CAARS, CANTAB and so on.
2020 | Year | 04 | Month | 13 | Day |
2021 | Year | 12 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045754